The NordICC-study group is nominated for the category Best Scientific Work by the Felix Burda Award 2017

Centre PI Michael Bretthauer and the NordICC-study group is nominated for the prestigious German research prize The Felix Burda Award 2017 for Best Scientific Work. The prize is awarded in Berlin on the 14 of May at a gala venue broadcasted on German television.

Principal investigator Michael Bretthauer

Link to news article in Norwegian from the The Clinical Effectiveness Research Group homepage: Norske leger nominert til prestisjetung tysk forskningspris

Latest publications

Thomsen et al., 2018. Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome. Br J Cancer 118(12):1609-1616 Mezheyeuski et al., 2018. Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer. Virchows Arch, 472(3): 395-405 Eide et al., 2018. Long non-coding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell-intrinsic properties. Int J Cancer, [Epub ahead of print] Guren et al., 2018. Rising incidence and improved survival of anal squamous cell carcinoma in Norway, 1987-2016. Clin Colorectal Cancer, [Epub ahead of print] Eilertsen IA et al., 2018. Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer. Int J Cancer, [Epub ahead of print] All publications